Our Winning Partnership to Counsel on and Defend Innovation
CASE STUDY
HOW WE DID IT
30+ years of collaboration with Genentech
MoFo’s work on behalf of Genentech has been instrumental to protecting the company’s lifesaving medicines. We have built a powerful industry team that leverages our collective intelligence to assist Genentech in its pioneering work in the biotechnology and pharmaceutical sectors.
Result
MoFo Team
Daralyn Durie
Environmental Law
Commercial Litigation
Trademark
IP Due Diligence
Patent Prosecution + Strategy
IP Litigation
Partner, San Francisco
Partner, Palo Alto
Catherine Polizzi
Partner, San Francisco
Michael Jacobs
Genentech
View Daralyn's Bio
View michael's Bio
View Catherine's Bio
MoFo Team
Result
Background
For more than 15 years, MoFo has provided strategic patent counseling and prosecution services for Genentech. Our team has helped develop the company’s strategy for its multibillion-dollar portfolios, including blockbuster cancer drugs Kadcyla, Perjeta, Gazyva, and Tecentriq. We have assisted Genentech in developing its patent portfolio related to innovations in the newer red-hot fields of bioinformatics, artificial intelligence, and machine learning.
Our team has the requisite experience needed to protect and enforce business-critical patents on behalf of Genentech in past successful matters, which includes acting as counsel in over a half-dozen lawsuits brought against the foundational and groundbreaking Cabilly family of patents, Patent Trial and Appeal Board (PTAB) proceedings against Merck, biosimilar Herceptin litigation, and Hatch-Waxman litigation. We have also successfully defended Genentech’s breakthrough innovations against lawsuits by others, defeating, for example, claims against Kadcyla and obtaining an award of attorney fees.
Background
HOW WE DID IT
Our Winning Partnership to Counsel on and Defend Innovation
Genentech
CASE STUDY
MoFo Team
Result
Background